
Aka gatabo gatanga amakuru yuzuye kuri ubuvuzi bushya butari buto kanseri y'ibihaha ivura hafi yawe. Tuzashakisha uburyo butandukanye bwo kuvura, ibintu ugomba gusuzuma muguhitamo gahunda yo kuvura, hamwe nibikoresho bigufasha kubona ubuvuzi bwiza.
Kanseri y'ibihaha itari ntoya (NSCLC) ni ubwoko bwa kanseri y'ibihaha ikunze kugaragara, bingana na 85% by'indwara zose zifata kanseri y'ibihaha. Yashyizwe mubice bitandukanye, buri kimwe gifite imiterere yacyo hamwe nubuvuzi. Kumenya hakiri kare ningirakamaro mugutezimbere ibisubizo byubuvuzi. Gusobanukirwa ubwoko bwihariye bwa NSCLC ni urufunguzo rwo gutegura gahunda nziza yo kuvura. Ugomba buri gihe kugisha inama umuganga wawe kugirango asuzume neza hamwe nibyifuzo byawe byo kuvura.
NSCLC yateguwe kugirango igaragaze urugero rwayo no kuyobora ibyemezo byo kuvura. Gutegura birimo ibizamini bitandukanye nka CT scan, PET scan, na biopsies. Ibyiciro bitangirira kuri I (byerekanwe) kugeza kuri IV (metastatike), hamwe na buri cyiciro gisaba uburyo butandukanye bwo kuvura. Kumenya icyiciro cya kanseri yawe bifasha kumenya ingamba zikwiye zo kuvura.
Kubaga nuburyo bwibanze bwo kuvura NSCLC yo hambere. Ubwoko bwo kubaga buterwa n'ahantu hamwe n'ubunini bw'ikibyimba. Amahitamo yo kubaga arimo lobectomy (kuvanaho ibihaha), pneumonectomy (kuvanaho ibihaha byose), hamwe no kwanga wedge (kuvanaho agace gato k'imitsi y'ibihaha). Tekinike yo kubaga byibura irashobora gukundwa, biganisha kubihe byihuse byo gukira. Kuvura nyuma yubuvuzi ni ngombwa kugirango ukire neza kandi wirinde ingorane.
Chimoterapi ikoresha imiti yica kanseri. Irashobora gukoreshwa mbere yo kubagwa (neoadjuvant chimiotherapie) kugirango igabanye ikibyimba, nyuma yo kubagwa (chimiotherapie adjuvant) kugirango ikureho kanseri zisigaye, cyangwa nkubuvuzi bwibanze bwa NSCLC. Uburyo butandukanye bwa chimiotherapie burahari, hamwe no guhitamo bitewe nibintu nkubuzima bwumurwayi muri rusange, icyiciro cya kanseri, nubwoko bwa NSCLC. Ingaruka kuruhande zirasanzwe kandi ziratandukanye ukurikije gahunda yihariye.
Imiti ivura imirasire ikoresha imirasire yingufu nyinshi kugirango isenye kanseri. Irashobora gukoreshwa wenyine cyangwa ifatanije nubundi buvuzi. Imiti ivura imishwarara yo hanze ni ubwoko busanzwe, butanga imirasire ivuye mumashini hanze yumubiri. Imiti ivura imirasire y'imbere (brachytherapy) ikubiyemo gushyira ibikoresho bya radiyoyoka mu kibyimba cyangwa hafi yacyo. Imiti ivura imirasire irashobora gutera ingaruka nkumunaniro, kurakara kuruhu, no kugira isesemi.
Ubuvuzi bugamije gukoresha imiti yibasira selile kanseri itangiza ingirabuzimafatizo nziza. Ubu buryo bwo kuvura bukoreshwa kuri NSCLC hamwe na mutation yihariye. Ingero zirimo EGFR inhibitor, ALK inhibitor, na PD-1 / PD-L1 inhibitor. Ubuvuzi bugamije bushobora kugira ingaruka zikomeye, kandi gukurikirana buri gihe birakenewe.
Immunotherapy ikoresha imbaraga z'umubiri zo kurwanya kanseri. Imiti ikingira indwara, nka inhibitori ya cheque, ifasha sisitemu yumubiri kumenya no gutera kanseri. Ubu buvuzi burashobora kuba ingirakamaro cyane, ariko kandi bufite ingaruka mbi. Immunotherapy ikoreshwa kenshi hamwe nubundi buvuzi cyangwa nkumuti wo murwego rwohejuru NSCLC.
Kubona ikigo gikwiye cya oncologue nubuvuzi ningirakamaro mukuvura kanseri neza. Reba ibintu nkuburambe, ubuhanga mubuvuzi bwa NSCLC, hamwe no gusuzuma abarwayi mugihe uhisemo. Ibitaro byinshi nibigo bya kanseri bitanga gahunda zihariye zo kuvura NSCLC. Ibikoresho byo kumurongo hamwe numuyoboro woherejwe nabaganga birashobora kugufasha kumenya inzobere zifite uburambe mukarere kawe. Wibuke kuganira kuburyo bwose bwo kuvura hamwe na muganga wawe kugirango umenye inzira nziza y'ibikorwa kubibazo byawe byihariye.
Kubijyanye no kuvura kanseri hamwe nuburyo bwo kuvura buhanitse, tekereza Shandong Baofa Ikigo Cyubushakashatsi Kanseri. Itsinda ryabo ryinzobere batanga ubuvuzi bugezweho no kwita kubantu bafite abarwayi kuvura udushya duto duto twa kanseri y'ibihaha.
Gahunda nziza yo kuvura kuri uburyo bushya bwo kuvura kanseri y'ibihaha biterwa nibintu byinshi, harimo icyiciro cya kanseri, ubuzima bwumurwayi muri rusange, nubwoko bwihariye bwa NSCLC. Gushyikirana kumugaragaro na muganga wawe nibyingenzi mugihe cyo kuvura. Amatsinda yo gushyigikira hamwe na serivisi zubujyanama zirashobora kandi gutanga inkunga yingirakamaro kumarangamutima kandi ifatika.
Inshingano: Aya makuru agamije uburezi gusa kandi ntabwo agizwe ninama zubuvuzi. Buri gihe ujye kwa muganga wawe kugirango asuzume kandi avure indwara iyo ari yo yose.
| Ubwoko bwo kuvura | Ibyiza | Ibibi |
|---|---|---|
| Kubaga | Irashobora gukiza hakiri kare NSCLC | Ntibishobora kuba bibereye abarwayi bose; ubushobozi bwo kugorana |
| Chimoterapi | Gukora mubyiciro bitandukanye bya NSCLC | Ingaruka zikomeye |
| Ubuvuzi | Irashobora kugabanya ibibyimba, kugabanya ibimenyetso | Ingaruka mbi nkumunaniro no kurwara uruhu |
| Ubuvuzi bugamije | Ireba selile yihariye ya kanseri | Ntishobora kuba ingirakamaro kubarwayi bose; ingaruka zishobora kubaho |
| Immunotherapy | Birashobora kuba byiza cyane; itera imbaraga z'umubiri | Ingaruka zishobora kubaho; ntishobora kuba ingirakamaro kubarwayi bose |
Icyitonderwa: Iyi mbonerahamwe itanga incamake rusange. Gahunda yo kuvura umuntu ku giti cye igomba kugenwa hifashishijwe impuguke mu by'ubuzima.